Skip to content

Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy

Breast Cancer

The hypothesis is that the daily use of brass mesh bolus achieves a comparable dose to every-other-day use of Superflab bolus (current standard of care) in chest wall post-mastectomy patients treated with rotational 6 MV photon delivery.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

Women undergoing rotational chest wall radiotherapy following mastectomy for breast cancer treatment who would utilize Superflab bolus on some, but not all, days of radiotherapy treatment.

Exclusion Criteria:

Patients who require daily bolus due to skin involvement or other high-risk features requiring a high skin dose will not be included.

Lieu de l'étude

Nova Scotia Health Authority
Nova Scotia Health Authority
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Primary Contact

Hannah Dahn, MD

[email protected]
902 473-6185
Étude parrainée par
Nova Scotia Cancer Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT05483712